XTL Biopharmaceuticals Ltd (XTLB) stock
XTLBNasdaqPharmaceutical Preparations
$1.60−0.04 (-2.44%)
Close on Nov 13, 2026Market cap $15.14MP/E –Yield –
XTL Biopharmaceuticals total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
XTL Biopharmaceuticals's total debt was $138.00K at Dec 31, 2024. For fiscal 2024 it was $138.00K.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $138.00K | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | $138.00K | – |
| Q3 FY2024 | Oct 15, 2024 | $163.00K | – |
See a number that looks wrong?